Skip to main content
Erschienen in: American Journal of Clinical Dermatology 4/2001

01.08.2001 | Review Article

Role of Lasers and Photodynamic Therapy in the Treatment of Cutaneous Malignancy

verfasst von: Dr Sigrid Karrer, Rolf-Markus Szeimies, Ulrich Hohenleutner, Michael Landthaler

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 4/2001

Einloggen, um Zugang zu erhalten

Abstract

Tumor therapy is not a common indication for the use of lasers, as it is in the treatment of benign vascular skin lesions, since many alternative treatment modalities exist. However, certain patients may benefit from laser therapy of premalignant and malignant skin tumors. Skin tumors can be treated by laser excision, laser coagulation, laser vaporization, or photodynamic therapy (PDT). For these purposes, the carbon dioxide laser, the neodymium:yttrium aluminum garnet laser and the argon laser are particularly suitable. PDT is a therapeutic approach based on the photosensitization of the target tissue by topical or systemic photosensitizers and subsequent irradiation with light from a laser or a lamp inducing cell death via generation of reactive oxygen species.
Laser therapy and PDT have shown good results in the curative treatment of actinic keratoses, superficial basal cell carcinoma, Bowen’s disease and cheilitis actinica. However, they are not recommended for primary malignant melanoma and invasive squamous cell carcinoma. In some patients, lasers and PDT might also be used effectively for the palliative treatment of cutaneous metastases.
In selected patients, lasers and PDT may offer some advantages over routine procedures, e.g. reduction of scarring and better cosmetic results. However, when treating invasive tumors with curative intention, one has to bear in mind the lack of histologic control and the limited depth of tissue penetration of most laser and PDT therapies.
Literatur
1.
Zurück zum Zitat Landthaler M, Hohenleutner U, editors. Lasertherapie in der Dermatologie. Atlas und Lehrbuch. Berlin, Heidelberg, New York: Springer, 1999 Landthaler M, Hohenleutner U, editors. Lasertherapie in der Dermatologie. Atlas und Lehrbuch. Berlin, Heidelberg, New York: Springer, 1999
2.
Zurück zum Zitat Walker N.P., Matthews J., Newson S.W. Possible hazards from irradiation with the carbon dioxide laser. Lasers Surg Med 1986; 6: 84–86PubMedCrossRef Walker N.P., Matthews J., Newson S.W. Possible hazards from irradiation with the carbon dioxide laser. Lasers Surg Med 1986; 6: 84–86PubMedCrossRef
3.
Zurück zum Zitat Landthaler M., Szeimies R.M., Hohenleutner U. Laser therapy of skin tumors. Recent Results Cancer Res 1995; 139: 417–421PubMedCrossRef Landthaler M., Szeimies R.M., Hohenleutner U. Laser therapy of skin tumors. Recent Results Cancer Res 1995; 139: 417–421PubMedCrossRef
4.
Zurück zum Zitat Von Tappeiner H., Jodlbauer A. Die sensibilisierende Wirkung fluorescierender Substanzen. Gesammette Untersuchungen über die photodynamische Erscheinung. Leipzig: FCW Vogel, 1907 Von Tappeiner H., Jodlbauer A. Die sensibilisierende Wirkung fluorescierender Substanzen. Gesammette Untersuchungen über die photodynamische Erscheinung. Leipzig: FCW Vogel, 1907
5.
Zurück zum Zitat Auler.H, Banzer G. Untersuchungen über die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren. Z Krebsforsch 1942; 53: 65–68CrossRef Auler.H, Banzer G. Untersuchungen über die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren. Z Krebsforsch 1942; 53: 65–68CrossRef
6.
Zurück zum Zitat Szeimies R.M., Sassy T., Landthaler M. Penetration potency of topical applied d-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol 1994; 59: 73–76PubMedCrossRef Szeimies R.M., Sassy T., Landthaler M. Penetration potency of topical applied d-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol 1994; 59: 73–76PubMedCrossRef
7.
Zurück zum Zitat Peng Q., Warloe T., Berg K., et al. 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 1997; 79: 2282–2308PubMedCrossRef Peng Q., Warloe T., Berg K., et al. 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 1997; 79: 2282–2308PubMedCrossRef
8.
Zurück zum Zitat Wheeland R.G., Bailin P.L., Ratz J.L., et al. Carbon dioxide laser vaporization and curettage in the treatment of large or multiple superficial basal cell carcinomas. J Dermatol Surg Oncol 1987; 13: 119–125PubMed Wheeland R.G., Bailin P.L., Ratz J.L., et al. Carbon dioxide laser vaporization and curettage in the treatment of large or multiple superficial basal cell carcinomas. J Dermatol Surg Oncol 1987; 13: 119–125PubMed
9.
Zurück zum Zitat Humphrey T.R., Malhotra R., Scharf M.J., et al. Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ with a high-energy pulsed carbon dioxide laser. Arch Dermatol 1998; 134: 1247–1252CrossRef Humphrey T.R., Malhotra R., Scharf M.J., et al. Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ with a high-energy pulsed carbon dioxide laser. Arch Dermatol 1998; 134: 1247–1252CrossRef
10.
Zurück zum Zitat Horlock N., Grobbelaar A.O., Gault D.T. Can the carbon dioxide laser completely ablate basal cell carcinomas? A histological study. Br J Plast Surg 2000; 53: 286–293PubMedCrossRef Horlock N., Grobbelaar A.O., Gault D.T. Can the carbon dioxide laser completely ablate basal cell carcinomas? A histological study. Br J Plast Surg 2000; 53: 286–293PubMedCrossRef
11.
Zurück zum Zitat Landthaler M., Brunner R., Haina D., et al. Der Neodym-YAG-Laser in der Dermatologie. Münch Med Wochenschr 1984; 126: 1108–1102 Landthaler M., Brunner R., Haina D., et al. Der Neodym-YAG-Laser in der Dermatologie. Münch Med Wochenschr 1984; 126: 1108–1102
12.
Zurück zum Zitat Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275–292PubMedCrossRef Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275–292PubMedCrossRef
13.
Zurück zum Zitat Fink-Puches R., Soyer H.P., Hofer A., et al. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical deltaaminolevulinic acid photodynamic therapy. Arch Dermatol 1998; 134: 821–826PubMedCrossRef Fink-Puches R., Soyer H.P., Hofer A., et al. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical deltaaminolevulinic acid photodynamic therapy. Arch Dermatol 1998; 134: 821–826PubMedCrossRef
14.
Zurück zum Zitat Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical deltaaminolevulinic acid as an appropriate approach to the route treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B 1995; 29: 53–57PubMedCrossRef Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical deltaaminolevulinic acid as an appropriate approach to the route treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B 1995; 29: 53–57PubMedCrossRef
15.
Zurück zum Zitat Svanberg K., Andersson T., Killander D., et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol 1994; 130: 743–751PubMedCrossRef Svanberg K., Andersson T., Killander D., et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol 1994; 130: 743–751PubMedCrossRef
16.
Zurück zum Zitat Karrer S., Szeimies R.M., Hohenleutner U., et al. Unilateral localized basaliomatosis: treatment with topical photodynamic therapy after application of 5-aminolevulinic acid. Dermatology 1995; 190: 218–222PubMedCrossRef Karrer S., Szeimies R.M., Hohenleutner U., et al. Unilateral localized basaliomatosis: treatment with topical photodynamic therapy after application of 5-aminolevulinic acid. Dermatology 1995; 190: 218–222PubMedCrossRef
17.
Zurück zum Zitat Meijnders P.J.N., Star W.M., De Bruijn R.S., et al. Clinical results of photodynamic therapy for superficial skin malignancies or actinic keratosis using topical 5-aminolevulinic acid. Las Med Science 1996; 11: 123–131CrossRef Meijnders P.J.N., Star W.M., De Bruijn R.S., et al. Clinical results of photodynamic therapy for superficial skin malignancies or actinic keratosis using topical 5-aminolevulinic acid. Las Med Science 1996; 11: 123–131CrossRef
18.
19.
Zurück zum Zitat Cox N.H., Eedy D.J., Morton C.A. Guidelines for management of Bowen’s disease. Br J Dermatol 1999; 141: 633–641PubMedCrossRef Cox N.H., Eedy D.J., Morton C.A. Guidelines for management of Bowen’s disease. Br J Dermatol 1999; 141: 633–641PubMedCrossRef
20.
Zurück zum Zitat Landthaler M., Haina D., Brunner R., et al. Laser therapy of Bowenoid papulosis and Bowen’s disease. J Dermatol Surg Oncol 1986; 12: 1253–1257PubMed Landthaler M., Haina D., Brunner R., et al. Laser therapy of Bowenoid papulosis and Bowen’s disease. J Dermatol Surg Oncol 1986; 12: 1253–1257PubMed
21.
Zurück zum Zitat Brunner R., Landthaler M., Haina D., et al. Treatment of benign semimalignant, and malignant skin tumors with the Nd-YAG-laser. Lasers Surg Med 1985; 5: 105–110PubMedCrossRef Brunner R., Landthaler M., Haina D., et al. Treatment of benign semimalignant, and malignant skin tumors with the Nd-YAG-laser. Lasers Surg Med 1985; 5: 105–110PubMedCrossRef
22.
Zurück zum Zitat Boynton K.K., Bjorkman D.J. Argon laser therapy for perianal Bowen’s disease: a case report. Lasers Surg Med 1991; 17: 385–387CrossRef Boynton K.K., Bjorkman D.J. Argon laser therapy for perianal Bowen’s disease: a case report. Lasers Surg Med 1991; 17: 385–387CrossRef
23.
Zurück zum Zitat Cairnduff F., Stringer M.R., Hudson E.J., et al. Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994; 69: 605–608PubMedCrossRef Cairnduff F., Stringer M.R., Hudson E.J., et al. Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994; 69: 605–608PubMedCrossRef
24.
Zurück zum Zitat Stables G.I., Stringer M.R., Robinson D.J., et al. The treatment of Bowen’s disease by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1998; 139: 74 Stables G.I., Stringer M.R., Robinson D.J., et al. The treatment of Bowen’s disease by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1998; 139: 74
25.
Zurück zum Zitat Morton C.A., Whitehurst C., Moseley H., et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen’s disease. Br J Dermatol 1996; 135: 766–771PubMedCrossRef Morton C.A., Whitehurst C., Moseley H., et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen’s disease. Br J Dermatol 1996; 135: 766–771PubMedCrossRef
26.
Zurück zum Zitat Fritsch C., Lang K., Neuse W., et al. Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol Appl Skin Physiol 1998; 11: 358–373PubMedCrossRef Fritsch C., Lang K., Neuse W., et al. Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol Appl Skin Physiol 1998; 11: 358–373PubMedCrossRef
27.
28.
Zurück zum Zitat Jiang S.B., Levine V.J., Nehal K.S., et al. Er: YAG laser for the treatment of actinic keratoses. Dermatol Surg 2000; 26: 437–440PubMedCrossRef Jiang S.B., Levine V.J., Nehal K.S., et al. Er: YAG laser for the treatment of actinic keratoses. Dermatol Surg 2000; 26: 437–440PubMedCrossRef
29.
Zurück zum Zitat Fulton J.E., Rahimi A.D., Helton P., et al. Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers. Dermatol Surg 1999; 25: 729–732PubMedCrossRef Fulton J.E., Rahimi A.D., Helton P., et al. Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers. Dermatol Surg 1999; 25: 729–732PubMedCrossRef
30.
Zurück zum Zitat Szeimies R.M., Karrer S., Sauerwald A., et al. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 1996; 192: 246–251PubMedCrossRef Szeimies R.M., Karrer S., Sauerwald A., et al. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 1996; 192: 246–251PubMedCrossRef
31.
Zurück zum Zitat Jeffes E.W., McCullough J.L., Weinstein G.D., et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid: a pilot dose-ranging study. Arch Dermatol 1997; 133: 727–732PubMedCrossRef Jeffes E.W., McCullough J.L., Weinstein G.D., et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid: a pilot dose-ranging study. Arch Dermatol 1997; 133: 727–732PubMedCrossRef
32.
Zurück zum Zitat Dougherty T.J., Gomer C.J., Henderson B.W., et al. Photodynamic Therapy. J Natl Cancer Inst 1998; 90: 889–905PubMedCrossRef Dougherty T.J., Gomer C.J., Henderson B.W., et al. Photodynamic Therapy. J Natl Cancer Inst 1998; 90: 889–905PubMedCrossRef
33.
Zurück zum Zitat Karrer S., Bäumler W., Abels C., et al. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Las Surg Med 1999; 25: 51–59CrossRef Karrer S., Bäumler W., Abels C., et al. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Las Surg Med 1999; 25: 51–59CrossRef
34.
Zurück zum Zitat David L.M. Laser vermilion ablation for actinic cheilitis. J Dermatol Surg Oncol 1985; 7: 520–523 David L.M. Laser vermilion ablation for actinic cheilitis. J Dermatol Surg Oncol 1985; 7: 520–523
35.
Zurück zum Zitat Hohenleutner U., Landthaler M., Hohenleutner S. CO2-Laservaporisation der Cheilitis actinica. Hautarzt 1999; 50: 562–565PubMedCrossRef Hohenleutner U., Landthaler M., Hohenleutner S. CO2-Laservaporisation der Cheilitis actinica. Hautarzt 1999; 50: 562–565PubMedCrossRef
36.
Zurück zum Zitat Fitzpatrick R.E., Goldman M.P., Ruiz-Esparza J. Clinical advantage of the CO2 laser superpulsed mode: treatment of verruca vulgaris, seborrheic keratoses, lentigines, and actinic cheilitis. J Dermatol Surg Oncol 1994; 20: 449–456PubMed Fitzpatrick R.E., Goldman M.P., Ruiz-Esparza J. Clinical advantage of the CO2 laser superpulsed mode: treatment of verruca vulgaris, seborrheic keratoses, lentigines, and actinic cheilitis. J Dermatol Surg Oncol 1994; 20: 449–456PubMed
37.
Zurück zum Zitat Stender I.M., Wulf H.C. Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis. Br J Dermatol 1996; 135: 454–456PubMedCrossRef Stender I.M., Wulf H.C. Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis. Br J Dermatol 1996; 135: 454–456PubMedCrossRef
38.
Zurück zum Zitat Horch H.H., Gerlach K.L., Schäfer H.E. CO2 laser surgery of oral premalignant lesions. Int J Oral Maxillofac Surg 1986; 15: 19–24PubMedCrossRef Horch H.H., Gerlach K.L., Schäfer H.E. CO2 laser surgery of oral premalignant lesions. Int J Oral Maxillofac Surg 1986; 15: 19–24PubMedCrossRef
39.
Zurück zum Zitat Chiesa R., Sala L., Costa L., et al. Excision of oral leukoplakias by CO2 laser on an outpatient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumor 1986; 72: 307–312 Chiesa R., Sala L., Costa L., et al. Excision of oral leukoplakias by CO2 laser on an outpatient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumor 1986; 72: 307–312
40.
Zurück zum Zitat Landthaler M., Brunner R., Haina D. Nd: YAG laser therapy of an oral verrucous leukoplakia. Dermatologica 1989; 178: 115–117PubMedCrossRef Landthaler M., Brunner R., Haina D. Nd: YAG laser therapy of an oral verrucous leukoplakia. Dermatologica 1989; 178: 115–117PubMedCrossRef
41.
Zurück zum Zitat Schoelch M.L., Sekandari N., Regezi J.A., et al. Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope 1999; 109: 949–953PubMedCrossRef Schoelch M.L., Sekandari N., Regezi J.A., et al. Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope 1999; 109: 949–953PubMedCrossRef
42.
Zurück zum Zitat Bernstein Z.P., Wilson D., Mang T.S. Pilot study PDT for treatment of AIDS-associated Kaposi sarcoma. Proc Am Soc Clin Oncol 1994; 13: 51 Bernstein Z.P., Wilson D., Mang T.S. Pilot study PDT for treatment of AIDS-associated Kaposi sarcoma. Proc Am Soc Clin Oncol 1994; 13: 51
43.
Zurück zum Zitat Abels C., Karrer S., Bäumler W., et al. Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi’s sarcoma. Br J Cancer 1998; 77: 1021–1024PubMedCrossRef Abels C., Karrer S., Bäumler W., et al. Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi’s sarcoma. Br J Cancer 1998; 77: 1021–1024PubMedCrossRef
44.
Zurück zum Zitat Wheeland R.G., Bailin P.L., Norris M.J. Argon laser photocoagulative therapy of Kaposi’s sarcoma: a clinical and histological evaluation. J Dermatol Surg Oncol 1985; 11: 1180–1185PubMed Wheeland R.G., Bailin P.L., Norris M.J. Argon laser photocoagulative therapy of Kaposi’s sarcoma: a clinical and histological evaluation. J Dermatol Surg Oncol 1985; 11: 1180–1185PubMed
45.
Zurück zum Zitat Tappero J.W., Grekin R.C., Zanelli G.A., et al. Pulsed-dye laser therapy for cutaneous Kaposi’s sarcoma associated with aquired immunodeficiency syndrome. J Am Acad Dermatol 1992; 27: 526–530PubMedCrossRef Tappero J.W., Grekin R.C., Zanelli G.A., et al. Pulsed-dye laser therapy for cutaneous Kaposi’s sarcoma associated with aquired immunodeficiency syndrome. J Am Acad Dermatol 1992; 27: 526–530PubMedCrossRef
46.
Zurück zum Zitat Orten S.S., Waner M., Dinehart S.M., et al. Q-switched neodymium: yttrium-aluminium-garnet laser treatment of lentigo maligna. Otolaryngol Head Neck Surg 1999; 120: 296–302PubMedCrossRef Orten S.S., Waner M., Dinehart S.M., et al. Q-switched neodymium: yttrium-aluminium-garnet laser treatment of lentigo maligna. Otolaryngol Head Neck Surg 1999; 120: 296–302PubMedCrossRef
47.
Zurück zum Zitat Arndt K.A. New pigmented macule appearing four years after argon laser treatment of lentigo maligna. J Am Acad Dermatol 1986; 14: 1092PubMedCrossRef Arndt K.A. New pigmented macule appearing four years after argon laser treatment of lentigo maligna. J Am Acad Dermatol 1986; 14: 1092PubMedCrossRef
48.
Zurück zum Zitat Kauvar A.N.B., Geronemus R.G. Treatment of lentigo maligna with the Q-switched ruby laser. Lasers Surg Med 1995; (Suppl. 7): 48 Kauvar A.N.B., Geronemus R.G. Treatment of lentigo maligna with the Q-switched ruby laser. Lasers Surg Med 1995; (Suppl. 7): 48
49.
Zurück zum Zitat Lee P.K., Rosenberg C.N., Taso H., et al. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol 1998; 38: 314–317PubMedCrossRef Lee P.K., Rosenberg C.N., Taso H., et al. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol 1998; 38: 314–317PubMedCrossRef
50.
Zurück zum Zitat Kopera D., Hohenleutner U., Stolz W., et al. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45 and Masson-positive cells. Dermatology 1997; 194: 344–350PubMedCrossRef Kopera D., Hohenleutner U., Stolz W., et al. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45 and Masson-positive cells. Dermatology 1997; 194: 344–350PubMedCrossRef
51.
Zurück zum Zitat Grob M., Senti G., Dummer R. Diganoseverzögerung bei einem amelanotischen Melanom durch CO2-Laserung. Fallbericht und Diskussion. Schweiz Rundsch Med Prax 1999; 88: 1491–494 Grob M., Senti G., Dummer R. Diganoseverzögerung bei einem amelanotischen Melanom durch CO2-Laserung. Fallbericht und Diskussion. Schweiz Rundsch Med Prax 1999; 88: 1491–494
52.
Zurück zum Zitat Kozlov A.P., Moskalik K.G. Pulsed laser radiation therapy of skin tumors. Cancer 1980; 46: 2172–2178PubMedCrossRef Kozlov A.P., Moskalik K.G. Pulsed laser radiation therapy of skin tumors. Cancer 1980; 46: 2172–2178PubMedCrossRef
53.
Zurück zum Zitat Hill S., Thomas J.M. Treatment of cutaneous metastases from malignant melanoma using the carbon-dioxide laser. Eur J Surg Oncol 1993; 19: 173–177PubMed Hill S., Thomas J.M. Treatment of cutaneous metastases from malignant melanoma using the carbon-dioxide laser. Eur J Surg Oncol 1993; 19: 173–177PubMed
54.
Zurück zum Zitat Hill S., Thomas J.M.. Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma. Br J Surg 1996; 83: 509–512PubMedCrossRef Hill S., Thomas J.M.. Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma. Br J Surg 1996; 83: 509–512PubMedCrossRef
55.
Zurück zum Zitat Lingam M.K., McKay A.J. Carbon dioxide laser ablation as an alternative treatment for cutaneous metastases form malignant melanoma. Br J Surg 1995; 82: 1346–1348PubMedCrossRef Lingam M.K., McKay A.J. Carbon dioxide laser ablation as an alternative treatment for cutaneous metastases form malignant melanoma. Br J Surg 1995; 82: 1346–1348PubMedCrossRef
56.
Zurück zum Zitat Karrer S., Abels C., Bäumler W., et al. Photochemotherapie von kutanen Rektumkarzinommetastasen mit Indocyaningrün. Dtsch Med Wochenschr 1997; 122: 1111–1114PubMedCrossRef Karrer S., Abels C., Bäumler W., et al. Photochemotherapie von kutanen Rektumkarzinommetastasen mit Indocyaningrün. Dtsch Med Wochenschr 1997; 122: 1111–1114PubMedCrossRef
57.
Zurück zum Zitat Lapes M., Petera J., Jirsa M. Photodynamic therapy of cutaneous metastases of breast cancer after local application of meso-tetra-(para-sulphophenyl)-porphin (TPPS4). J Photochem Photobiol B 1996; 36: 205–207PubMedCrossRef Lapes M., Petera J., Jirsa M. Photodynamic therapy of cutaneous metastases of breast cancer after local application of meso-tetra-(para-sulphophenyl)-porphin (TPPS4). J Photochem Photobiol B 1996; 36: 205–207PubMedCrossRef
58.
Zurück zum Zitat Kaplan M.J., Somers R.G., Greenberg R.H., et al. Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2). J Surg Oncol 1998; 67: 121–125PubMedCrossRef Kaplan M.J., Somers R.G., Greenberg R.H., et al. Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2). J Surg Oncol 1998; 67: 121–125PubMedCrossRef
59.
Zurück zum Zitat Mang T.S., Allison R., Hewson G., et al. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am 1998; 4: 378–384PubMed Mang T.S., Allison R., Hewson G., et al. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am 1998; 4: 378–384PubMed
Metadaten
Titel
Role of Lasers and Photodynamic Therapy in the Treatment of Cutaneous Malignancy
verfasst von
Dr Sigrid Karrer
Rolf-Markus Szeimies
Ulrich Hohenleutner
Michael Landthaler
Publikationsdatum
01.08.2001
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 4/2001
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200102040-00004

Weitere Artikel der Ausgabe 4/2001

American Journal of Clinical Dermatology 4/2001 Zur Ausgabe

Review Article

Exogenous Ochronosis

Review Article

Oral Cancer

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.